Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 6—June 2010


Enterovirus Genotype EV-104 in Humans, Italy, 2008–2009

Antonio Piralla, Francesca Rovida, Fausto Baldanti, and Giuseppe GernaComments to Author 
Author affiliations: Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico, San Matteo, Pavia, Italy

Main Article


Characteristics of 5 patients with HEV genotype EV-104 infection, Pavia, Italy, 2009*

Patient no. Sample no. Age, y/sex Hospital department, date of admission Respiratory secretion Ct value
Clinical symptoms Underlying disease Virus identified/ coinfecting virus (Ct)
Pav-1 NPA/9210 60/M Hematology outpatient, Apr 29.67 Undetected Fever, cough, rhinorrhea HSCT (AML) EV-104
Pav-2 NPA/9570 62/M Infectious Diseases outpatient, Apr 23.06 23.05 Chronic rhinopharyngitis None EV-104
Pav-3 NPA/11228 7/F Pediatric Oncohematology, May 33.64 Undetected Fever, rhinorrhea, conjunctivitis AML (chemotherapy) EV-104
Pav-4 NPA/11230 37/F Infectious Diseases outpatient, May 32.60 Undetected Chronic rhinopharyngitis None EV-104
Pav-5 NPA/13174 2/M Pediatric Oncohematology, Jun 23.78 31.61 Cough, rhinorrhea, diarrhea, wheezing HSCT (AML) EV-104/RSV (18.53)

*HEV, human enterovirus; Ct, cycle threshold; HRV, human rhinovirus; NPA, nasopharyngeal aspirate; HSCT, hematopoietic stem cell transplant; AML, acute myelocytic leukemia; RSV, respiratory syncytial virus.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO